Vaccine advisers to the US Food and Drug Administration voted easily and quickly to recommend that the agency give emergency use authorization to Moderna’s coronavirus vaccine — but not without a lengthy side discussion about whether volunteers in the clinical trial who got placebo shots should be offered the vaccine early.
Vaccine advisers to the US Food and Drug Administration voted easily and quickly to recommend that the agency give emergency use authorization to Moderna’s coronavirus vaccine — but not without a lengthy side discussion about whether volunteers in the clinical trial who got placebo shots should be offered the vaccine early.
